PRKAA2 and endocrine system disorder: A study performed in obese individuals with no endocrine disorder showed that oral administration of higher dose of RSV (500 mg three times/day for 4 weeks) resulted in no improvement in insulin sensitivity, gene expression or inflammatory markers and no increase in AMPK and acetyl-CoA carboxylase activation [78].